Fever and bleeding illness study in East and Central Africa
Part of Digestive system, Infections clinical trials.
This study looks at people with fever or unexplained bleeding in East and Central Africa to learn more about illnesses like Rift Valley fever. By joining, you can help doctors understand and better treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 10 years or older (or 2 years or older for the household part of the study)
- Have a fever now (temperature of 99.5°F or higher) or have had a fever in the past 4 weeks
- Have tested negative for malaria (or positive for malaria, depending on the group)
- Have unexplained bleeding, such as blood in vomit, bleeding gums, nosebleeds, red eyes, or bleeding from other body parts
- Have an illness that needs hospital care and is not getting better with usual treatments for 7 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how safe a Rift Valley fever (RVF) vaccine is and how strongly it triggers the body’s immune response. You may be eligible if you are at risk of RVF exposure and your blood test shows you don’t already have strong protection.
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
This study looks at how hemorrhagic fever with renal syndrome (a viral infection that can cause bleeding and kidney problems) affects the body's ability to clot blood. The findings may help improve care for patients with this condition.
This study follows people with confirmed brucellosis, epidemic hemorrhagic fever, or kala-azar (visceral leishmaniasis) to understand how these infections behave in real life. It may help improve care by collecting evidence on diagnosis and treatment outcomes.
This study is looking at people in Cambodia who have a fever or have been in close contact with someone who has a certain infection. Researchers will use a new type of DNA test to try to find the cause of the fever.
Hear when a new Rift Valley Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.